AVXL vs BBLG

Anavex Life Sciences Corp. vs Bone Biologics Corp — Valuation Comparison 2026

AVXL

Biotechnology
Anavex Life Sciences Corp.
Quality
4.3
out of 10
Value Trap
6
SAFE
Price
$2.94
Last close
Models
10/13
Active
VS

BBLG

Biotechnology
Bone Biologics Corp
Quality
3.7
out of 10
Value Trap
12
SAFE
Price
$1.30
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType AVXL Fair ValueAVXL Upside BBLG Fair ValueBBLG Upside
Bayesian DCF Intrinsic $1.56 -46.8% $1.73 +32.6%
Earnings Power Value Intrinsic $1.52 -54.1%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.37 -88.8% $0.30 -76.9%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for AVXL vs BBLG — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AVXL vs BBLG — Which Stock Is More Undervalued?

AVXL scores higher with a 4.3/10 quality rating vs BBLG's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Anavex Life Sciences Corp. (AVXL) and Bone Biologics Corp (BBLG) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AVXL currently trades at $2.94 with a QOC of 4.3/10, while BBLG trades at $1.30 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).